Management Team

Dr Mike Capaldi

Mike has held senior roles in the pharmaceutical and life sciences industry since 1982, both in the UK and the USA. Previous large companies included Ciba Geigy, SmithKline & French and Amersham International where he headed up the Drug Development Services in the USA – later becoming an Executive Vice-President in Nycomed Amersham’s healthcare division. For the last 18 years, Mike has worked in the biotech/technology sector serving as executive director on the Boards of both publically listed and private companies including Core Group plc, Oxford Asymmetry plc, Mindweavers plc, Synaptica Ltd, Scancell plc, Hunter-Fleming Ltd and CMP Therapeutics Ltd (in the latter four companies as CEO). Mike is also currently a non-executive director of Stealthyx Therapeutics, Roslin Cells and Synaptica. He joined Edinburgh BioQuarter as Director in 2010 before founding Sunergos Innovations in October 2015.

+44 (0)131 651 7896 +44 (0)131 651 7896

Iain Reid
Chief Financial Officer

Iain was previously Finance Director of the National Trust for Scotland. Prior to this he had spells as Finance Director for Grant Management (UK) Ltd, Axway Software SA and Sopra Group. Before this he was Chief Operating Officer for Scottish Widows Investment Partnership (SWIP). Iain trained as a Chartered Accountant with KPMG Peat Marwick before moving on to become a corporate finance partner in Rutherford Manson Dowds CA.

+44 (0)7916 799 233 +44 (0)7916 799 233

Dr Howard Marriage

Howard is a serial entrepreneur, having been actively involved in numerous companies, both large and small. His early career was spent in Genzyme, ending up as Senior Director of Corporate Development in Europe. He joined Cyclacel in 1998 and became Executive Director Research Operations and Business Development. He left Cyclacel in 2004 to found his own consultancy company, Biotech Innovation and Future Health. Since then, Howard has founded and raised finance for numerous companies, still serving as Chairman for many of these including Chivaron, Dundee Cell Products, NeurocentRx, and Aquila Biomedical. He is also a non-executive director of ProPharm and Symbiosis. Howard has been working with Edinburgh University since 2006.

+44 (0)7714 677 890 +44 (0)7714 677 890

Dr Giles Dudley
Head of Company Creation - Edinburgh

Giles joined BioQuarter formally in 2011 although he had been previously working with the BioQuarter team in his role as Edinburgh Research and Innovation’s Business Development Manager for the University of Edinburgh’s College of Medicine and Veterinary Medicine. Giles has nearly a decade’s worth of experience in commercial roles in the healthcare sector, including business development, licensing, new venture formation, product development and general management. Before coming to Edinburgh, he worked at Invitrogen and was a Business Enterprise Fellow at Oxford University & Isis Innovation (one of the UK’s leading technology transfer organisation).  Giles has a PhD in Virology from the University of Glasgow.

+44 (0)7702 129 649 +44 (0)7702 129 649

Dr Emma Mickley
Director of Business Development

Emma joined Sunergos Innovations in November 2015 from Aptuit. Prior to that she was VP Corporate Business Development at Aesica Pharmaceuticals, a contract pharmaceutical and manufacturing company in the USA. Previous to that, she had worked in three other contract research organisations: CXR Biosciences, Charles River Laboratories and Quinitiles. Before entering contract research, Emma worked as an analyst and business consultant at Wood Mackenzie Consultants.

+44 (0)7739 796 179 +44 (0)7739 796 179